FDA mulls "behind-the-counter" system for some drugs

The FDA said it will hold a hearing on Nov. 14 to discuss the possibility of allowing more drugs to be sold without a prescription through a "behind-the-counter" system. The system may allow pharmacists to determine whether a patient has met the requirements to receive certain medications and to guide patients on their proper use, according to a notice issued by the agency in today's Federal Register.

View Full Article in:

Chicago Tribune (tiered subscription model) · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park